New program teaches teens with diabetes to talk to doctors and take charge
NCT ID NCT03734107
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a program called PREP-DC that teaches teens and young adults with type 1 diabetes how to communicate better with their doctors and get ready for adult diabetes care. 52 participants aged 17-23 were split into two groups: one received the program, the other got standard care. Researchers tracked blood sugar levels, clinic visits, and self-care habits to see if the program helps during this tricky transition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Behavioral intervention (PREP-DC: Plan, Reflect, and Engage with Providers for Diabetes Care)
What this could lead to
If it works, this program could help teens with type 1 diabetes manage their care better and have smoother transitions to adult clinics, potentially improving blood sugar control.
What could go wrong
This is a small, completed study with only 52 participants. The intervention is behavioral, so results may vary widely and may not apply to everyone. It does not test a drug or cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's National Health System
Washington D.C., District of Columbia, 20010, United States